Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

GenMont Biotech, Inc. (3164) Financial Statements

GenMont Biotech, Inc. Financial Overview

GenMont Biotech, Inc.'s market cap is currently NT$1.44B. The company's EPS TTM is NT$0.81; its P/E ratio is 20.68; and it has a dividend yield of 4.78%. GenMont Biotech, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 401.23MNT$ 385.37MNT$ 318.01MNT$ 368.55MNT$ 427.93M
Gross ProfitNT$ 251.63MNT$ 238.18MNT$ 211.19MNT$ 256.72MNT$ 299.33M
Operating IncomeNT$ 57.75MNT$ 40.12MNT$ 6.99MNT$ 60.18MNT$ 143.49M
EBITDANT$ 124.57MNT$ 140.03MNT$ 93.92MNT$ 117.43MNT$ 161.29M
Net IncomeNT$ 57.20MNT$ 57.25MNT$ 32.99MNT$ 56.98MNT$ 113.13M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 432.80MNT$ 425.81MNT$ 328.30MNT$ 400.94MNT$ 421.73M
Total AssetsNT$ 1.67BNT$ 1.71BNT$ 1.65BNT$ 1.70BNT$ 1.70B
Total DebtNT$ 110.31MNT$ 118.61MNT$ 58.31MNT$ 34.55MNT$ 32.73M
Net DebtNT$ 6.58MNT$ 8.10MNT$ 2.71MNT$ -99.14MNT$ -137.22M
Total LiabilitiesNT$ 215.35MNT$ 229.06MNT$ 204.06MNT$ 198.59MNT$ 173.65M
Stockholders' EquityNT$ 1.33BNT$ 1.35BNT$ 1.32BNT$ 1.35BNT$ 1.38B
Cash Flow
Free Cash FlowNT$ 69.94MNT$ 79.67MNT$ -941.00KNT$ 66.04MNT$ -5.46M
Operating Cash FlowNT$ 73.60MNT$ 123.95MNT$ 34.60MNT$ 137.95MNT$ 111.66M
Investing Cash FlowNT$ 7.70MNT$ -82.42MNT$ -75.37MNT$ -82.73MNT$ -153.07M
Financing Cash FlowNT$ -88.64MNT$ 12.55MNT$ -36.82MNT$ -91.08MNT$ -61.37M

Currency in TWD

GenMont Biotech, Inc. Earnings and Revenue History

0150M300M450M0 %15 %30 %45 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

GenMont Biotech, Inc. Liabilities to Assets

0600M1.2B1.8B4 %8 %12 %16 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

GenMont Biotech, Inc. Cash Flow

-200M-100M0100M200M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

GenMont Biotech, Inc. Forecast EPS vs Actual EPS

00.10.10.20.20.30.30.4Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >